Page last updated: 2024-10-17

phosphonoacetic acid and Cytomegalovirus Infections

phosphonoacetic acid has been researched along with Cytomegalovirus Infections in 126 studies

Phosphonoacetic Acid: A simple organophosphorus compound that inhibits DNA polymerase, especially in viruses and is used as an antiviral agent.
phosphonoacetic acid : A member of the class of phosphonic acids that is phosphonic acid in which the hydrogen attached to the phosphorous is replaced by a carboxymethyl group.

Cytomegalovirus Infections: Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults.

Research Excerpts

ExcerptRelevanceReference
"In a controlled trial of foscarnet in the treatment of cytomegalovirus (CMV) retinitis in patients with the acquired immunodeficiency syndrome (AIDS), patients with non-immediately sight-threatening lesions were randomized to receive immediate treatment with foscarnet or foscarnet treatment delayed until the first signs of retinitis progression."9.07Design of a randomized controlled trial of foscarnet in patients with cytomegalovirus retinitis associated with acquired immunodeficiency syndrome. ( Polis, MA, 1992)
"To evaluate foscarnet sodium in treating cytomegalovirus retinitis in patients with AIDS."9.07A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. ( Baird, BF; Davey, RT; Davis, M; De Smet, MD; Falloon, J; Kovacs, JA; Palestine, AG; Polis, MA; Zunich, KM; Zurlo, JJ, 1991)
"Circulating human immunodeficiency virus (HIV) p24 antigen levels were measured in 22 AIDS patients who had detectable serum antigen at baseline after induction and maintenance therapy of foscarnet for cytomegalovirus retinitis in phase I/II multicenter trials."9.07Effect of foscarnet therapy on human immunodeficiency virus p24 antigen levels in AIDS patients with cytomegalovirus retinitis. ( Causey, DM; Davis, RB; Grieco, MH; Hooton, TM; Jacobson, MA; McKinley, GF; Parenti, DM; Reddy, MM; van der Horst, CM, 1992)
"These results suggest that for patients with AIDS, and cytomegalovirus retinitis, treatment with foscarnet offers a survival advantage over treatment with ganciclovir, although the patients may not tolerate foscarnet as well as ganciclovir."9.07Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. ( , 1992)
"Ganciclovir and Foscarnet were compared in an open randomised trial as treatment and secondary prophylaxis of cytomegalovirus (CMV) retinitis in patients with AIDS."9.07Foscarnet and Ganciclovir in the treatment of CMV retinitis in AIDS patients: a randomised comparison. ( Gazzard, BG; Harman, C; Mathalone, B; Mitchell, S; Moyle, G, 1992)
"Intravenous foscarnet was given on an emergency basis to 30 immunosuppressed patients with cytomegalovirus (CMV) disease, of whom 28 were organ transplant recipients."9.06Sensitivity of cytomegalovirus to intravenous foscarnet treatment. ( Akesson-Johansson, A; Lernestedt, JO; Lönnqvist, B; Ringdén, O; Wahren, B, 1986)
"The use of ganciclovir in the treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS) is limited by marrow toxicity and by the development of resistance to this agent in CMV strains capable of causing progressive disease."8.78Maintenance therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: foscarnet. ( Jacobson, MA, 1992)
"The pyrophosphate analogue, foscarnet, selectively inhibits the DNA polymerase of human herpes viruses, including cytomegalovirus, and the reverse transcriptase of HIV."8.78Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. ( Chrisp, P; Clissold, SP, 1991)
"Induction regimens of foscarnet and ganciclovir are highly effective in arresting cytomegalovirus (CMV) retinitis in patients with AIDS."8.78Foscarnet and ganciclovir in the treatment of cytomegalovirus retinitis. ( Polis, MA, 1992)
"Ganciclovir and foscarnet are both effective for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome, but the benefits of either agent given alone are limited."7.68Treatment of aggressive cytomegalovirus retinitis with ganciclovir in combination with foscarnet in a child infected with human immunodeficiency virus. ( Butler, KM; De Smet, MD; Husson, RN; Jarosinski, P; Lovato, G; Manjunath, K; Montrella, K; Mueller, B; Nussenblatt, RB; Pizzo, PA, 1992)
"Foscarnet is an investigational antiviral agent that has been used effectively in the treatment of cytomegalovirus (CMV) retinitis in AIDS patients."7.68Successful foscarnet therapy for cytomegalovirus retinitis in an AIDS patient undergoing hemodialysis: rationale for empiric dosing and plasma level monitoring. ( Gambertoglio, JG; Graziani, AL; Grunwald, JE; MacGregor, RR; Weiss, R, 1991)
"Foscarnet, administered via a central line, was used for the treatment of 18 episodes of cytomegalovirus (CMV) esophageal ulceration in 15 patients, and in the treatment of 27 episodes of CMV colitis in 22 patients."7.68Foscarnet in the treatment of cytomegalovirus infection of the esophagus and colon in patients with the acquired immune deficiency syndrome. ( Connolly, GM; Gazzard, BG; Hawkins, DA; Nelson, MR, 1991)
"Infections caused by cytomegalovirus (CMV) resistant in vitro to ganciclovir, defined as requiring greater than 6 mumols of ganciclovir for ED50 have developed in some AIDS patients with progressive CMV retinitis despite chronic ganciclovir therapy."7.68Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS. ( Drew, WL; Feinberg, J; Jacobson, MA; Miner, RD; O'Donnell, JJ; Parenti, D; Whitmore, PV, 1991)
"Ten patients with acquired immunodeficiency syndrome with newly diagnosed cytomegalovirus (CMV) retinitis were treated with an induction regimen of intravenous foscarnet, 60 mg/kg of body weight, administered as a 2-h infusion and repeated every 8 h for 14 days."7.67Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. ( Jacobson, MA; Mills, J; O'Donnell, JJ, 1989)
"Eight patients, 7 renal and 1 combined renal and pancreas allograft recipients with generalized cytomegalovirus (CMV) infection were treated with continuous intravenous foscarnet infusion (0."7.67Evaluation by immune scanning electron microscopy of foscarnet treatment of cytomegalovirus infection in patients with renal transplants. ( Akesson-Johansson, A; Andersson, J; Brattström, C, 1989)
" Following allogeneic bone marrow transplantation, he developed cytomegalovirus retinitis, which was treated successfully with trisodium phosphonoformate (foscarnet)."7.67Foscarnet as treatment for cytomegalovirus retinitis following bone marrow transplantation. ( Arthur, C; Ganly, PS; Goldman, JM; Schulenburg, WE, 1988)
"Treatment with Foscarnet may be initially effective, but does not eliminate cytomegalovirus infection."6.66Cytomegalovirus colitis and oesophageal ulceration in the context of AIDS: clinical manifestations and preliminary report of treatment with Foscarnet (phosphonoformate). ( Barrison, I; Boylston, A; Forster, S; Jeffries, DJ; Pinching, AJ; Thom, S; Unwin, R; Weber, JN, 1987)
"Foscarnet has a low solubility and a high degree of ionization at physiologic pH, requiring it to be administered in higher doses and larger volumes."6.38Approaches to the treatment of cytomegalovirus retinitis: ganciclovir and foscarnet. ( Jacobson, MA; O'Donnell, JJ, 1991)
"Foscarnet was discontinued because of adverse events in 3 (3%) of 97 patients, with treatment being stopped in 2 patients because of renal insufficiency and in 1 patient because of an acute neurologic disorder."5.28Foscarnet induction therapy for cytomegalovirus retinitis in AIDS: comparison of twice-daily and three-times-daily regimens. ( Brancon, C; Caumes, E; Cochereau-Massin, I; Dahan, R; Dohin, E; Gentilini, M; Katlama, C; Robinet, M; Rogeaux, O, 1992)
"Foscarnet was given as a continuous intravenous infusion."5.28Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients. ( Aschan, J; Ljungman, P; Lönnqvist, B; Ohlman, S; Ringdén, O, 1992)
"Eight patients with acquired immunodeficiency syndrome and serious CMV retinitis received 2-h intravenous infusions of foscarnet at a dosage of 60 mg/kg of body weight every 8 h for 14 days."5.28Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis. ( Aweeka, F; Gambertoglio, J; Jacobson, MA; Mills, J, 1989)
" Adverse effects, such as decreased haemoglobin, decreased renal function and increased serum calcium, were observed in a few patients only."5.27Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients. ( Ahlmén, J; Klintmalm, G; Lernestedt, JO; Lönnqvist, B; Paulin, T; Ringdén, O; Wahren, B, 1986)
"In a controlled trial of foscarnet in the treatment of cytomegalovirus (CMV) retinitis in patients with the acquired immunodeficiency syndrome (AIDS), patients with non-immediately sight-threatening lesions were randomized to receive immediate treatment with foscarnet or foscarnet treatment delayed until the first signs of retinitis progression."5.07Design of a randomized controlled trial of foscarnet in patients with cytomegalovirus retinitis associated with acquired immunodeficiency syndrome. ( Polis, MA, 1992)
"These results suggest that for patients with AIDS, and cytomegalovirus retinitis, treatment with foscarnet offers a survival advantage over treatment with ganciclovir, although the patients may not tolerate foscarnet as well as ganciclovir."5.07Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. ( , 1992)
"To evaluate foscarnet sodium in treating cytomegalovirus retinitis in patients with AIDS."5.07A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. ( Baird, BF; Davey, RT; Davis, M; De Smet, MD; Falloon, J; Kovacs, JA; Palestine, AG; Polis, MA; Zunich, KM; Zurlo, JJ, 1991)
"Circulating human immunodeficiency virus (HIV) p24 antigen levels were measured in 22 AIDS patients who had detectable serum antigen at baseline after induction and maintenance therapy of foscarnet for cytomegalovirus retinitis in phase I/II multicenter trials."5.07Effect of foscarnet therapy on human immunodeficiency virus p24 antigen levels in AIDS patients with cytomegalovirus retinitis. ( Causey, DM; Davis, RB; Grieco, MH; Hooton, TM; Jacobson, MA; McKinley, GF; Parenti, DM; Reddy, MM; van der Horst, CM, 1992)
"Ganciclovir and Foscarnet were compared in an open randomised trial as treatment and secondary prophylaxis of cytomegalovirus (CMV) retinitis in patients with AIDS."5.07Foscarnet and Ganciclovir in the treatment of CMV retinitis in AIDS patients: a randomised comparison. ( Gazzard, BG; Harman, C; Mathalone, B; Mitchell, S; Moyle, G, 1992)
"Intravenous foscarnet was given on an emergency basis to 30 immunosuppressed patients with cytomegalovirus (CMV) disease, of whom 28 were organ transplant recipients."5.06Sensitivity of cytomegalovirus to intravenous foscarnet treatment. ( Akesson-Johansson, A; Lernestedt, JO; Lönnqvist, B; Ringdén, O; Wahren, B, 1986)
"Induction regimens of foscarnet and ganciclovir are highly effective in arresting cytomegalovirus (CMV) retinitis in patients with AIDS."4.78Foscarnet and ganciclovir in the treatment of cytomegalovirus retinitis. ( Polis, MA, 1992)
"The use of ganciclovir in the treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS) is limited by marrow toxicity and by the development of resistance to this agent in CMV strains capable of causing progressive disease."4.78Maintenance therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: foscarnet. ( Jacobson, MA, 1992)
" The antiviral agents ganciclovir and foscarnet are effective against CMV retinitis and gastrointestinal diseases, although dose-limiting adverse effects and the need for long-term maintenance therapy may hinder their use in many patients."4.78Treatment and prophylaxis of cytomegalovirus disease. ( Jacobson, PA; Levinson, ML, 1992)
"The pyrophosphate analogue, foscarnet, selectively inhibits the DNA polymerase of human herpes viruses, including cytomegalovirus, and the reverse transcriptase of HIV."4.78Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. ( Chrisp, P; Clissold, SP, 1991)
"Drug-resistant human cytomegalovirus (HCMV) strains were selected in human embryonic lung (HEL) fibroblasts under pressure of the (S)-3-hydroxy-2-phosphonylmethoxypropyl (HPMP) derivatives of cytosine (HPMPC) and adenine (HPMPA), the 2-phosphonylmethoxyethyl (PME) derivative of 2,6-diaminopurine (PMEDAP), ganciclovir (GCV), acyclovir (ACV), and foscarnet (PFA)."3.69Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro. ( Andrei, G; De Clercq, E; Snoeck, R, 1996)
"Infections caused by cytomegalovirus (CMV) resistant in vitro to ganciclovir, defined as requiring greater than 6 mumols of ganciclovir for ED50 have developed in some AIDS patients with progressive CMV retinitis despite chronic ganciclovir therapy."3.68Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS. ( Drew, WL; Feinberg, J; Jacobson, MA; Miner, RD; O'Donnell, JJ; Parenti, D; Whitmore, PV, 1991)
"Ganciclovir and foscarnet are both effective for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome, but the benefits of either agent given alone are limited."3.68Treatment of aggressive cytomegalovirus retinitis with ganciclovir in combination with foscarnet in a child infected with human immunodeficiency virus. ( Butler, KM; De Smet, MD; Husson, RN; Jarosinski, P; Lovato, G; Manjunath, K; Montrella, K; Mueller, B; Nussenblatt, RB; Pizzo, PA, 1992)
"Foscarnet and ganciclovir appear to be of similar effectiveness in halting active infection when given as induction therapy and in forestalling progression of disease when given as maintenance therapy in persons with AIDS who have cytomegalovirus (CMV) retinitis."3.68Therapeutic algorithm for treatment of cytomegalovirus retinitis in persons with AIDS. A roundtable summary. ( Balfour, HH; Drew, WL; Hardy, WD; Heinemann, MH; Polsky, B, 1992)
"Foscarnet, administered via a central line, was used for the treatment of 18 episodes of cytomegalovirus (CMV) esophageal ulceration in 15 patients, and in the treatment of 27 episodes of CMV colitis in 22 patients."3.68Foscarnet in the treatment of cytomegalovirus infection of the esophagus and colon in patients with the acquired immune deficiency syndrome. ( Connolly, GM; Gazzard, BG; Hawkins, DA; Nelson, MR, 1991)
"Foscarnet is an investigational antiviral agent that has been used effectively in the treatment of cytomegalovirus (CMV) retinitis in AIDS patients."3.68Successful foscarnet therapy for cytomegalovirus retinitis in an AIDS patient undergoing hemodialysis: rationale for empiric dosing and plasma level monitoring. ( Gambertoglio, JG; Graziani, AL; Grunwald, JE; MacGregor, RR; Weiss, R, 1991)
" Following allogeneic bone marrow transplantation, he developed cytomegalovirus retinitis, which was treated successfully with trisodium phosphonoformate (foscarnet)."3.67Foscarnet as treatment for cytomegalovirus retinitis following bone marrow transplantation. ( Arthur, C; Ganly, PS; Goldman, JM; Schulenburg, WE, 1988)
"Eight patients, 7 renal and 1 combined renal and pancreas allograft recipients with generalized cytomegalovirus (CMV) infection were treated with continuous intravenous foscarnet infusion (0."3.67Evaluation by immune scanning electron microscopy of foscarnet treatment of cytomegalovirus infection in patients with renal transplants. ( Akesson-Johansson, A; Andersson, J; Brattström, C, 1989)
"Ten patients with acquired immunodeficiency syndrome with newly diagnosed cytomegalovirus (CMV) retinitis were treated with an induction regimen of intravenous foscarnet, 60 mg/kg of body weight, administered as a 2-h infusion and repeated every 8 h for 14 days."3.67Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. ( Jacobson, MA; Mills, J; O'Donnell, JJ, 1989)
"Foscarnet was administered as a continuous infusion of 200 mg/kg (prior to 1988) or as an intermittent infusion of 60 mg/kg t."2.67Treatment of HIV-related cytomegalovirus disease of the gastrointestinal tract with foscarnet. ( Blanshard, C, 1992)
"Treatment with Foscarnet may be initially effective, but does not eliminate cytomegalovirus infection."2.66Cytomegalovirus colitis and oesophageal ulceration in the context of AIDS: clinical manifestations and preliminary report of treatment with Foscarnet (phosphonoformate). ( Barrison, I; Boylston, A; Forster, S; Jeffries, DJ; Pinching, AJ; Thom, S; Unwin, R; Weber, JN, 1987)
"Foscarnet has a low solubility and a high degree of ionization at physiologic pH, requiring it to be administered in higher doses and larger volumes."2.38Approaches to the treatment of cytomegalovirus retinitis: ganciclovir and foscarnet. ( Jacobson, MA; O'Donnell, JJ, 1991)
"CMV disease is a major problem in AIDS, though with a different profile from that seen in other immunosuppressed patients."2.38Cytomegalovirus infection in the acquired immune deficiency syndrome. ( Pinching, AJ, 1989)
"How to treat cytomegalovirus infections in patients infected with the human immunodeficiency virus constitutes one of the best examples of the quandaries engendered by these advances, and the topic is reviewed in this first AIDS Commentary update."2.38Cytomegalovirus infection in patients with AIDS. ( Drew, WL, 1992)
" Myelosuppression may be further exacerbated in AIDS patients by such other agents as zidovudine or trimethoprim/sulfamethoxazole, often necessitating dosage reductions or discontinuation of these agents in patients receiving ganciclovir."2.38Foscarnet sodium. ( Baltz, JK; Minor, JR, 1991)
"Acyclovir is a prototype of this improved process."2.37Promising new antiviral drugs. ( Bryson, YJ, 1988)
" An important direction for future clinical research is the development of more effective and less toxic therapy, as well as orally bioavailable drugs for maintenance therapy."2.37Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment. ( Jacobson, MA; Mills, J, 1988)
"Cytomegalovirus retinitis is probably the result of hematogenous spread of the virus to the retina after systemic reactivation of a latent cytomegalovirus infection."2.37The diagnosis of cytomegalovirus retinitis. ( Bloom, JN; Palestine, AG, 1988)
"Foscarnet was given as a continuous intravenous infusion."1.28Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients. ( Aschan, J; Ljungman, P; Lönnqvist, B; Ohlman, S; Ringdén, O, 1992)
"Foscarnet was discontinued because of adverse events in 3 (3%) of 97 patients, with treatment being stopped in 2 patients because of renal insufficiency and in 1 patient because of an acute neurologic disorder."1.28Foscarnet induction therapy for cytomegalovirus retinitis in AIDS: comparison of twice-daily and three-times-daily regimens. ( Brancon, C; Caumes, E; Cochereau-Massin, I; Dahan, R; Dohin, E; Gentilini, M; Katlama, C; Robinet, M; Rogeaux, O, 1992)
"Eight patients with acquired immunodeficiency syndrome and serious CMV retinitis received 2-h intravenous infusions of foscarnet at a dosage of 60 mg/kg of body weight every 8 h for 14 days."1.28Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis. ( Aweeka, F; Gambertoglio, J; Jacobson, MA; Mills, J, 1989)
"Fifty AIDS patients were investigated for human cytomegalovirus (HCMV) viraemia when potentially HCMV-related clinical symptoms or syndromes were observed."1.28Early virus isolation, early structural antigen detection and DNA amplification by the polymerase chain reaction in polymorphonuclear leukocytes from AIDS patients with human cytomegalovirus viraemia. ( Gaballo, A; Gerna, G; Milanesi, G; Parea, M; Percivalle, E; Zavattoni, M; Zipeto, D, 1991)
" Therefore we began treatment with trisodium phosphonoformate (Foscavir) at a dosage of 60 mg/kg body weight per day (3 weeks), continuing with maintenance therapy at 90 mg/kg body weight per day (7 days a week)."1.28[Therapeutic alternative or 2d choice drug. Trisodium phosphonoformate in cytomegalovirus retinitis]. ( Gümbel, H; Helm, EB; Ohrloff, C; Schalnus, R, 1991)
"Foscarnet-induced acute renal failure was defined as a rise in serum creatinine of at least 25% from the basal value."1.28Foscarnet nephrotoxicity: mechanism, incidence and prevention. ( Baumelou, A; Beaufils, H; Danis, M; Deray, G; Dohin, E; Gentilini, M; Katlama, C; Levaltier, B; Martinez, F; Rozenheim, M, 1989)
"Neutropenia was the most frequent and serious side-effect of ganciclovir, 76% patients having neutrophil counts less than 1."1.28Cytomegalovirus infection in AIDS. Patterns of disease, response to therapy and trends in survival. ( Anderson, S; Beck, EJ; Coker, R; Coleman, D; Harris, JR; Main, J; Migdal, C; Peters, BS; Pinching, AJ, 1991)
" Maintenance therapy with DHPG would appear to be necessary to prevent relapse, but the logistics of this are difficult, and the effective dosage of DHPG is as yet uncertain."1.27Treatment of CMV retinitis in an AIDS patient. ( Acheson, JF; Bradbeer, C; Shah, SM; Spalton, DJ; Thin, RN, 1987)
"Foscarnet (FC) is a new antiviral agent which has been recently proposed for the treatment of severe cytomegalovirus (CMV) infections in immunocompromised patients."1.27Acute renal failure induced by foscarnet: 4 cases. ( Baumelou, A; Cacoub, P; Deray, G; Gentilini, M; Jacobs, C; Le Hoang, P; Rousselie, R; Rozenbaum, W; Soubrie, C, 1988)
" The dosage of Foscarnet was increased during the study."1.27Clinical experiences with phosphonoformate (foscarnet) treatment of viral diseases following renal transplantation. ( Ahlmén, J; Brynger, H; Lycke, E; Wijnween, AC, 1985)
" Adverse effects, such as decreased haemoglobin, decreased renal function and increased serum calcium, were observed in a few patients only."1.27Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients. ( Ahlmén, J; Klintmalm, G; Lernestedt, JO; Lönnqvist, B; Paulin, T; Ringdén, O; Wahren, B, 1986)
"Foscarnet was administered to eight AIDS patients for suspected cytomegalovirus (CMV) pneumonitis as a continuous intravenous infusion for a minimum of 8 days."1.27Treatment of cytomegalovirus pneumonitis with foscarnet (trisodium phosphonoformate) in patients with AIDS. ( Anderson, MG; Chanas, AC; Ellis, ME; Farthing, C; Gazzard, BG, 1987)

Research

Studies (126)

TimeframeStudies, this research(%)All Research%
pre-199044 (34.92)18.7374
1990's82 (65.08)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Radsak, K1
Wiegandt, H1
Burns, WH1
Wingard, JR1
Sandford, GR1
Bender, WJ1
Saral, R1
Lucia, HL1
Griffith, BP1
Hsiung, GD1
Snoeck, R2
Andrei, G1
De Clercq, E2
Timmerman, JJ1
Beersma, MF1
van Gijlswijk-Janssen, DJ1
van Es, LA1
van der Woude, FJ1
Daha, MR1
Healy, B1
Hirsch, MS1
Masur, H1
Heinemann, MH2
Polis, MA3
Jacobson, MA12
Jabs, DA1
Butler, KM1
De Smet, MD2
Husson, RN1
Mueller, B1
Manjunath, K1
Montrella, K1
Lovato, G1
Jarosinski, P1
Nussenblatt, RB1
Pizzo, PA1
Salit, IE1
Evans, JK1
Scoular, A1
Miller, RF1
Drew, WL3
Nicoli, F1
Dhiver, C1
Chave, B1
Poizot-Martin, I1
Gastaut, JA1
Gastaut, JL1
Cerrina, J1
Le Roy Ladurie, F1
Wilson, RJ1
Skolnik, PR1
Deray, G4
Katlama, C5
Jacobs, C2
Bachman, DM1
Peters, M1
Timm, U1
Schürmann, D1
Pohle, HD1
Ruf, B1
Dohin, E3
Caumes, E1
Cochereau-Massin, I1
Brancon, C1
Robinet, M2
Rogeaux, O2
Dahan, R1
Gentilini, M3
Blanshard, C1
Balfour, HH1
Hardy, WD1
Polsky, B1
Manji, H1
Malin, A1
Connolly, S1
Evans, LM1
Grossman, ME1
Cotte, L1
Langlois, M1
Trepo, C1
Aschan, J2
Ringdén, O6
Ljungman, P1
Lönnqvist, B6
Ohlman, S1
Reusser, P1
Gambertoglio, JG2
Lilleby, K1
Meyers, JD3
Reddy, MM1
Grieco, MH1
McKinley, GF1
Causey, DM1
van der Horst, CM1
Parenti, DM1
Hooton, TM1
Davis, RB1
Levinson, ML1
Jacobson, PA1
Moyle, G1
Harman, C1
Mitchell, S1
Mathalone, B1
Gazzard, BG5
Bedos, JP1
Wolf, M1
Vachon, F1
Morris, DJ1
Wood, CA1
Enting, R1
de Gans, J1
Reiss, P2
Jansen, C1
Portegies, P1
Feinberg, J1
O'Donnell, JJ5
Whitmore, PV1
Miner, RD1
Parenti, D1
Petersen, EA1
Reed, EC2
Nelson, MR2
Connolly, GM2
Hawkins, DA2
Charpentier, B1
Drobyski, WR2
Knox, KK2
Carrigan, DR2
Ash, RC1
MacGregor, RR1
Graziani, AL1
Weiss, R1
Grunwald, JE1
Palestine, AG2
Baird, BF1
Falloon, J1
Kovacs, JA1
Davey, RT1
Zurlo, JJ1
Zunich, KM1
Davis, M1
Marwick, C1
Moeland, A1
Bruun, JN1
Smyth, RL1
Scott, JP1
Borysiewicz, LK1
Sharples, LD1
Stewart, S1
Wreghitt, TG1
Gray, JJ1
Higenbottam, TW1
Wallwork, J1
Nightingale, SL1
Minor, JR2
Peters, BS2
Beck, EJ1
Anderson, S1
Coleman, D1
Coker, R1
Main, J1
Migdal, C2
Harris, JR2
Pinching, AJ4
Lowenstein, W1
Fadlallah, JP1
Roudière, L1
Deneux, C1
Haas, C1
Durand, H1
Harb, GE1
Bacchetti, P1
Gerna, G1
Zipeto, D1
Parea, M1
Percivalle, E1
Zavattoni, M1
Gaballo, A1
Milanesi, G1
Gümbel, H1
Ohrloff, C1
Schalnus, R1
Helm, EB1
Neyts, J1
Schols, D1
Himpens, B1
Jenkins, RE1
Barter, G1
Hawkins, D1
Coker, RJ1
Tomlinson, D1
Horner, P1
Griffiths, PD1
Chrisp, P1
Clissold, SP1
Paul, AA1
Leeper, HF1
Friberg, TR1
Söderlund, C1
Bratt, G1
Grützmeier, S1
Rieger, A1
Sandström, E1
Sjunnesson, M1
Henderly, DE1
Jampol, LM1
Baltz, JK1
Van Der Pijl, JW1
Frissen, PH1
Hulsebosch, HJ1
Van Den Tweel, JG1
Lange, JM1
Danner, SA1
Youle, M1
Chanas, A2
Gazzard, B1
Leport, C1
Salmon, D1
Fanning, MM2
Read, SE2
Benson, M1
Vas, S1
Rachlis, A2
Kozousek, V1
Mortimer, C1
Harvey, P1
Schwartz, C1
Chew, E2
Farese, RV1
Schambelan, M1
Hollander, H1
Stringari, S1
Cotton, P1
Bryson, YJ1
Sakuma, T1
Azuma, M1
Chiba, S1
Lehoang, P1
Girard, B1
Marcel, P1
Zazoun, L1
Matheron, S1
Rozenbaum, W2
Morer, I1
Lernestedt, JO6
Mills, J5
Aweeka, F2
Gambertoglio, J2
Martinez, F1
Levaltier, B1
Beaufils, H1
Danis, M1
Rozenheim, M1
Baumelou, A2
Sundberg, B1
Andersson, J1
Akesson-Johansson, A3
Brattström, C1
Nyberg, G1
Svalander, C1
Blohmé, I1
Persson, H1
Wood, G1
Whitby, M1
Hogan, P1
Frazer, I1
Acheson, JF1
Shah, SM1
Spalton, DJ1
Bradbeer, C1
Thin, RN1
Debs, RJ1
Montgomery, AB1
Brunette, EN1
DeBruin, M1
Shanley, JD1
Walmsley, SL1
Vellend, H1
Salit, I1
Cacoub, P1
Le Hoang, P2
Soubrie, C1
Rousselie, R1
Wahren, B4
Crowe, S1
Levy, J1
McManus, N1
Rush, J1
Miller, RG1
Greco, C1
Gonzales, MF1
Bloom, JN1
Ganly, PS1
Arthur, C1
Goldman, JM2
Schulenburg, WE2
Wyngaarden, JB1
Michon, C1
Girard, PM1
Ngovan, P1
Simonpoli, AM1
Apperley, JF1
Marcus, RE1
Wardle, DG1
Gravett, PJ1
Wilczek, H1
Gahrton, G2
Heley, A1
Klintmalm, G2
Oberg, B1
Lundgren, G1
Robert, KH1
Groth, CG1
Singer, DR1
Fallon, TJ1
Williams, G1
Cohen, J1
Ahlmén, J2
Wijnween, AC1
Brynger, H1
Lycke, E1
Paulin, T1
Larson, A1
Frödin, L2
Tufveson, G2
Larsson, E1
Källander, CF2
Gronowitz, JS2
Larsson, A1
Claesson, K1
Sjöberg, O1
Brochard, L1
Salmeron, S1
Herve, P1
Petitpretz, P1
Boissonnas, A1
Simonneau, G1
Duroux, P1
Weber, JN1
Thom, S1
Barrison, I1
Unwin, R1
Forster, S1
Jeffries, DJ1
Boylston, A1
Gluckman, E1
Keable, H1
Meletis, J1
Bombail, D1
Jolivet, I1
Huart, JJ1
Nebout, T1
Cavazzana, M1
De Castro, H1
Farthing, C1
Anderson, MG1
Ellis, ME1
Chanas, AC1

Clinical Trials (5)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Foscarnet-Ganciclovir CMV Retinitis Trial[NCT00000136]Phase 3234 participants (Actual)Interventional1990-03-31Completed
Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component[NCT00000665]240 participants InterventionalCompleted
A Phase II Randomized Controlled Trial of Immediate Versus Delayed Foscarnet Therapy in AIDS Patients With Non-Immediately Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due to Myelosuppression[NCT00000697]Phase 20 participants (Actual)InterventionalWithdrawn
A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure[NCT00000691]Phase 2156 participants InterventionalCompleted
Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome[NCT00000726]Phase 153 participants InterventionalCompleted
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Mortality

(NCT00000136)
Timeframe: All patients enrolled will be followed until a common study closing date, which was chosen to provide a minimum of 1 year of follow-up for all patients enrolled in the trial.

Interventionparticipants (Number)
Foscarnet107
Ganciclovir127

Reviews

26 reviews available for phosphonoacetic acid and Cytomegalovirus Infections

ArticleYear
Characteristics of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.
    The American journal of medicine, 1992, Feb-14, Volume: 92, Issue:2A

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Vi

1992
Maintenance therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: foscarnet.
    The American journal of medicine, 1992, Feb-14, Volume: 92, Issue:2A

    Topics: Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Eye Infections, Viral; Fosc

1992
Cytomegalovirus infection in patients with AIDS.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992, Volume: 14, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Chorioretinitis; Cytomegalovirus Infections; Encephalitis; Fosca

1992
[Cytomegalovirus infection in patients after lung transplantation].
    Presse medicale (Paris, France : 1983), 1992, Mar-21, Volume: 21, Issue:11

    Topics: Acyclovir; Antiviral Agents; Blood Transfusion; Cytomegalovirus; Cytomegalovirus Infections; Foscarn

1992
Cytomegalovirus retinitis in AIDS.
    Journal of the American Optometric Association, 1992, Volume: 63, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Diagnosis, Differe

1992
Combined and alternating ganciclovir and foscarnet in acute and maintenance therapy of human immunodeficiency virus-related cytomegalovirus encephalitis refractory to ganciclovir alone. A case report and review of the literature.
    The Clinical investigator, 1992, Volume: 70, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infect

1992
Foscarnet and ganciclovir in the treatment of cytomegalovirus retinitis.
    Journal of acquired immune deficiency syndromes, 1992, Volume: 5 Suppl 1

    Topics: Cytomegalovirus Infections; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Phosphonoacet

1992
Foscarnet-induced penile ulcer.
    Journal of the American Academy of Dermatology, 1992, Volume: 27, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet;

1992
Treatment and prophylaxis of cytomegalovirus disease.
    Pharmacotherapy, 1992, Volume: 12, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Gancicl

1992
Extrapulmonary cytomegalovirus disease in transplant patients.
    Transplantation proceedings, 1991, Volume: 23, Issue:2 Suppl 1

    Topics: Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus Infections; Foscarnet; Ganciclovir; H

1991
Treatment of cytomegalovirus pneumonia in transplant patients.
    Transplantation proceedings, 1991, Volume: 23, Issue:2 Suppl 1

    Topics: Cytomegalovirus Infections; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Immunization,

1991
[Cytomegalovirus infections in transplant patients].
    Presse medicale (Paris, France : 1983), 1991, Jun-22, Volume: 20, Issue:24

    Topics: Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immune Tolerance; Inci

1991
[Treatment of herpesvirus infections].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1991, Sep-20, Volume: 111, Issue:22

    Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Microbial; Foscarnet; Ganc

1991
Advances in the prevention and treatment of cytomegalovirus infection in hospital patients.
    The Journal of hospital infection, 1991, Volume: 18 Suppl A

    Topics: Antibodies, Monoclonal; Antiviral Agents; Bronchoalveolar Lavage Fluid; Cross Infection; Cytomegalov

1991
Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis.
    Drugs, 1991, Volume: 41, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Anemia; Animals; Antiviral Agents; Cytomegalovirus; Cytomegalovi

1991
Approaches to the treatment of cytomegalovirus retinitis: ganciclovir and foscarnet.
    Journal of acquired immune deficiency syndromes, 1991, Volume: 4 Suppl 1

    Topics: Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Eye Infections, Viral; Fosc

1991
Diagnosis and treatment of cytomegalovirus retinitis.
    Journal of acquired immune deficiency syndromes, 1991, Volume: 4 Suppl 1

    Topics: Antiviral Agents; Cytomegalovirus Infections; Diagnosis, Differential; Eye Infections, Viral; Foscar

1991
Foscarnet sodium.
    DICP : the annals of pharmacotherapy, 1991, Volume: 25, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Vi

1991
Treatment of cytomegalovirus infection.
    Clinics in laboratory medicine, 1987, Volume: 7, Issue:4

    Topics: Acyclovir; Clinical Trials as Topic; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Imm

1987
Promising new antiviral drugs.
    Journal of the American Academy of Dermatology, 1988, Volume: 18, Issue:1 Pt 2

    Topics: Acyclovir; Animals; Antiviral Agents; Bromodeoxyuridine; Cytomegalovirus Infections; Foscarnet; Ganc

1988
Cotton-wool spots and cytomegalovirus retinitis in AIDS.
    International ophthalmology clinics, 1989,Summer, Volume: 29, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Cytomegalovirus Infections; Diabetic Retinopathy; Dia

1989
Cytomegalovirus infection in the acquired immune deficiency syndrome.
    The Journal of antimicrobial chemotherapy, 1989, Volume: 23 Suppl E

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Addison Disease; Antiviral Agents; Colitis; Cytomegal

1989
Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment.
    Annals of internal medicine, 1988, Volume: 108, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarn

1988
Management of cytomegalovirus infection.
    The American journal of medicine, 1988, Aug-29, Volume: 85, Issue:2A

    Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunizatio

1988
The diagnosis of cytomegalovirus retinitis.
    Annals of internal medicine, 1988, Dec-15, Volume: 109, Issue:12

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Diagnos

1988
[Treatment of cytomegalovirus infections in immunosuppressed patients].
    Annales de medecine interne, 1988, Volume: 139, Issue:7

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarn

1988

Trials

16 trials available for phosphonoacetic acid and Cytomegalovirus Infections

ArticleYear
The treatment of cytomegalovirus in AIDS--more than meets the eye.
    The New England journal of medicine, 1992, Jan-23, Volume: 326, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Comb

1992
Design of a randomized controlled trial of foscarnet in patients with cytomegalovirus retinitis associated with acquired immunodeficiency syndrome.
    The American journal of medicine, 1992, Feb-14, Volume: 92, Issue:2A

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Eye Infecti

1992
Studies of ocular complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 1. Rationale, design, and methods. AIDS Clinical Trials Group (ACTG).
    Controlled clinical trials, 1992, Volume: 13, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Infe

1992
Studies of ocular complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 1. Rationale, design, and methods. AIDS Clinical Trials Group (ACTG).
    Controlled clinical trials, 1992, Volume: 13, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Infe

1992
Studies of ocular complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 1. Rationale, design, and methods. AIDS Clinical Trials Group (ACTG).
    Controlled clinical trials, 1992, Volume: 13, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Infe

1992
Studies of ocular complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 1. Rationale, design, and methods. AIDS Clinical Trials Group (ACTG).
    Controlled clinical trials, 1992, Volume: 13, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Infe

1992
Treatment of HIV-related cytomegalovirus disease of the gastrointestinal tract with foscarnet.
    Journal of acquired immune deficiency syndromes, 1992, Volume: 5 Suppl 1

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Female; Foscarnet;

1992
Phase I-II trial of foscarnet for prevention of cytomegalovirus infection in autologous and allogeneic marrow transplant recipients.
    The Journal of infectious diseases, 1992, Volume: 166, Issue:3

    Topics: Adolescent; Adult; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus Infections; Drug E

1992
Effect of foscarnet therapy on human immunodeficiency virus p24 antigen levels in AIDS patients with cytomegalovirus retinitis.
    The Journal of infectious diseases, 1992, Volume: 166, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Adult; Cytomegalovirus Infections; Dose-Response Relationship, D

1992
Foscarnet and Ganciclovir in the treatment of CMV retinitis in AIDS patients: a randomised comparison.
    The Journal of infection, 1992, Volume: 25, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Gancicl

1992
Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis.
    The New England journal of medicine, 1992, 01-23, Volume: 326, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; CD4-Positive T-Lymphocytes; Cytomegalov

1992
Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis.
    The New England journal of medicine, 1992, 01-23, Volume: 326, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; CD4-Positive T-Lymphocytes; Cytomegalov

1992
Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis.
    The New England journal of medicine, 1992, 01-23, Volume: 326, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; CD4-Positive T-Lymphocytes; Cytomegalov

1992
Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis.
    The New England journal of medicine, 1992, 01-23, Volume: 326, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; CD4-Positive T-Lymphocytes; Cytomegalov

1992
AIDS file.
    The American journal of nursing, 1991, Volume: 91, Issue:10

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Gancicl

1991
A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS.
    Annals of internal medicine, 1991, Nov-01, Volume: 115, Issue:9

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Eye Infecti

1991
Foscarnet versus ganciclovir in the management of cytomegalovirus disease in patients with AIDS.
    American journal of hospital pharmacy, 1991, Volume: 48, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Gancicl

1991
Treatment of acquired immune deficiency syndrome (AIDS)-related pneumonitis with foscarnet: a double-blind placebo controlled study.
    The Journal of infection, 1990, Volume: 20, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; D

1990
Treatment of cytomegalovirus infection.
    Clinics in laboratory medicine, 1987, Volume: 7, Issue:4

    Topics: Acyclovir; Clinical Trials as Topic; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Imm

1987
Sensitivity of cytomegalovirus to intravenous foscarnet treatment.
    Bone marrow transplantation, 1986, Volume: 1, Issue:2

    Topics: Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Female;

1986
From the National Institutes of Health. Progress in AIDS research.
    JAMA, 1988, Dec-16, Volume: 260, Issue:23

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Infe

1988
Cytomegalovirus colitis and oesophageal ulceration in the context of AIDS: clinical manifestations and preliminary report of treatment with Foscarnet (phosphonoformate).
    Gut, 1987, Volume: 28, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Adult; Clinical Trials as Topic; Colitis; Cytomegalovirus Infect

1987

Other Studies

85 other studies available for phosphonoacetic acid and Cytomegalovirus Infections

ArticleYear
Glycosphingolipid synthesis in human fibroblasts infected by cytomegalovirus.
    Virology, 1984, Oct-30, Volume: 138, Issue:2

    Topics: Cell Differentiation; Cells, Cultured; Cytomegalovirus Infections; Glycosphingolipids; Humans; Isoel

1984
Acyclovir in mouse cytomegalovirus infections.
    The American journal of medicine, 1982, Jul-20, Volume: 73, Issue:1A

    Topics: Acyclovir; Animals; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance;

1982
Effect of acyclovir and phosphonoformate on cytomegalovirus infection in guinea pigs.
    Intervirology, 1984, Volume: 21, Issue:3

    Topics: Acyclovir; Animals; Antiviral Agents; Cytomegalovirus Infections; Disease Models, Animal; Foscarnet;

1984
Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1996, Volume: 15, Issue:7

    Topics: Acyclovir; Adenine; Antiviral Agents; Cells, Cultured; Cidofovir; Cytarabine; Cytomegalovirus; Cytom

1996
Differential effects of cytomegalovirus infection on complement synthesis by human mesangial cells.
    Clinical and experimental immunology, 1997, Volume: 109, Issue:3

    Topics: Blotting, Northern; Cells, Cultured; Complement C2; Complement C4; Complement Factor B; Complement F

1997
From the National Institutes of Health.
    JAMA, 1992, Jan-08, Volume: 267, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Arthr

1992
Foscarnet.
    The Medical letter on drugs and therapeutics, 1992, Jan-10, Volume: 34, Issue:861

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Vi

1992
Didanosine and foscarnet marketed for use by patients with AIDS.
    Clinical pharmacy, 1992, Volume: 11, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Didanosine; Foscar

1992
Clinical implications of herpesvirus infections in patients with AIDS. Introduction.
    The American journal of medicine, 1992, Feb-14, Volume: 92, Issue:2A

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Vi

1992
Treatment of cytomegalovirus retinitis--1992.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1992, Volume: 110, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Vi

1992
Treatment of aggressive cytomegalovirus retinitis with ganciclovir in combination with foscarnet in a child infected with human immunodeficiency virus.
    The Journal of pediatrics, 1992, Volume: 120, Issue:3

    Topics: Antiviral Agents; Child, Preschool; Cytomegalovirus Infections; Drug Therapy, Combination; Female; F

1992
Why was treatment of cytomegalovirus retinitis randomized?
    Annals of internal medicine, 1992, Apr-01, Volume: 116, Issue:7

    Topics: Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans;

1992
Cytomegalovirus and AIDS.
    Genitourinary medicine, 1992, Volume: 68, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet;

1992
[Regressive diffuse leukoencephalitis under foscarnet in an AIDS infected patient].
    Presse medicale (Paris, France : 1983), 1992, Mar-07, Volume: 21, Issue:9

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Encephalitis; Fosc

1992
Treatment of CMV retinitis.
    The New England journal of medicine, 1992, Jun-18, Volume: 326, Issue:25

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Comb

1992
Treatment of CMV retinitis.
    The New England journal of medicine, 1992, Jun-18, Volume: 326, Issue:25

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Gancicl

1992
Treatment of CMV retinitis.
    The New England journal of medicine, 1992, Jun-18, Volume: 326, Issue:25

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Gancicl

1992
Foscarnet induction therapy for cytomegalovirus retinitis in AIDS: comparison of twice-daily and three-times-daily regimens.
    Journal of acquired immune deficiency syndromes, 1992, Volume: 5 Suppl 1

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Drug Admini

1992
Therapeutic algorithm for treatment of cytomegalovirus retinitis in persons with AIDS. A roundtable summary.
    Journal of acquired immune deficiency syndromes, 1992, Volume: 5 Suppl 1

    Topics: Acquired Immunodeficiency Syndrome; Adult; Algorithms; Cytomegalovirus Infections; Foscarnet; Gancic

1992
CMV polyradiculopathy in AIDS--suggestions for new strategies in treatment.
    Genitourinary medicine, 1992, Volume: 68, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Adult; Cytomegalovirus Infections; Foscarnet; Humans; Male; Nerv

1992
Herpes simplex virus infection during foscarnet therapy.
    The Journal of infectious diseases, 1992, Volume: 166, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet;

1992
Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients.
    Scandinavian journal of infectious diseases, 1992, Volume: 24, Issue:2

    Topics: Adolescent; Adult; Antiviral Agents; Bone Marrow Transplantation; Calcium; Child; Child, Preschool;

1992
[Myelo-meningoradiculitis secondary to cytomegalovirus infection in a non immunocompromised patient. Treatment with foscarnet].
    Annales de medecine interne, 1992, Volume: 143, Issue:3

    Topics: Adolescent; Antiviral Agents; Bone Marrow Diseases; Cytomegalovirus Infections; Foscarnet; Humans; M

1992
Treatment of CMV retinitis.
    Lancet (London, England), 1992, Jan-25, Volume: 339, Issue:8787

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Vi

1992
Foscarnet for CMV retinitis.
    Lancet (London, England), 1992, Feb-22, Volume: 339, Issue:8791

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Gancicl

1992
Ganciclovir/foscarnet for cytomegalovirus meningoencephalitis in AIDS.
    Lancet (London, England), 1992, Aug-29, Volume: 340, Issue:8818

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Drug Therap

1992
Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS.
    The Journal of infectious diseases, 1991, Volume: 163, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infect

1991
Foscarnet in the treatment of cytomegalovirus infection of the esophagus and colon in patients with the acquired immune deficiency syndrome.
    The American journal of gastroenterology, 1991, Volume: 86, Issue:7

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Colitis; Cytomegalovirus Infections; Es

1991
Foscarnet therapy of ganciclovir-resistant cytomegalovirus in marrow transplantation.
    Transplantation, 1991, Volume: 52, Issue:1

    Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovirus Infections; D

1991
Successful foscarnet therapy for cytomegalovirus retinitis in an AIDS patient undergoing hemodialysis: rationale for empiric dosing and plasma level monitoring.
    The Journal of infectious diseases, 1991, Volume: 164, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adult; Antiviral Agents; Cytomegalovirus In

1991
National Eye Institute issues clinical alert about CMV retinitis in AIDS.
    JAMA, 1991, Nov-20, Volume: 266, Issue:19

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Vi

1991
Foscarnet approved for cytomegalovirus retinitis.
    American family physician, 1991, Volume: 44, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Humans;

1991
Cytomegalovirus infection in heart-lung transplant recipients: risk factors, clinical associations, and response to treatment.
    The Journal of infectious diseases, 1991, Volume: 164, Issue:6

    Topics: Adolescent; Adult; Antibodies, Viral; Bacterial Infections; Child; Cytomegalovirus; Cytomegalovirus

1991
From the Food and Drug Administration.
    JAMA, 1991, Dec-18, Volume: 266, Issue:23

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Vi

1991
Cytomegalovirus infection in AIDS. Patterns of disease, response to therapy and trends in survival.
    The Journal of infection, 1991, Volume: 23, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Colitis; Cytomegalovirus Infections; Female; F

1991
[Prevention of genital erosions during treatments with foscarnet of cytomegalovirus infections in AIDS].
    Presse medicale (Paris, France : 1983), 1991, Nov-23, Volume: 20, Issue:39

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet;

1991
Survival of patients with AIDS and cytomegalovirus disease treated with ganciclovir or foscarnet.
    AIDS (London, England), 1991, Volume: 5, Issue:8

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Female; Fos

1991
Early virus isolation, early structural antigen detection and DNA amplification by the polymerase chain reaction in polymorphonuclear leukocytes from AIDS patients with human cytomegalovirus viraemia.
    Molecular and cellular probes, 1991, Volume: 5, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Antigens, Viral; Antiviral Agents; Cytomegalovirus; Cytomegalovi

1991
[Therapeutic alternative or 2d choice drug. Trisodium phosphonoformate in cytomegalovirus retinitis].
    Fortschritte der Ophthalmologie : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 1991, Volume: 88, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Chorioretinitis; Cytomegalovirus Infections; D

1991
Sensitive, reproducible and convenient fluorometric assay for the in vitro evaluation of anti-cytomegalovirus agents.
    Journal of virological methods, 1991, Volume: 35, Issue:1

    Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Ester

1991
Thromboembolic disease in AIDS is associated with cytomegalovirus disease.
    AIDS (London, England), 1991, Volume: 5, Issue:12

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet;

1991
Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient.
    Lancet (London, England), 1991, May-25, Volume: 337, Issue:8752

    Topics: Adult; Antiviral Agents; Bone Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Drug Res

1991
Simultaneous treatment of cytomegalovirus retinitis with ganciclovir and foscarnet.
    Lancet (London, England), 1991, Jul-27, Volume: 338, Issue:8761

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Eye Infecti

1991
Treatment of cytomegalovirus retinitis with ganciclovir and foscarnet.
    Lancet (London, England), 1991, Aug-31, Volume: 338, Issue:8766

    Topics: Adult; Cytomegalovirus Infections; Drug Combinations; Foscarnet; Ganciclovir; HIV Seropositivity; Hu

1991
Seeing the way forward for treatment of CMV retinitis.
    Lancet (London, England), 1991, Dec-14, Volume: 338, Issue:8781

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Infe

1991
CMV retinitis and the use of FK 506.
    Transplantation proceedings, 1991, Volume: 23, Issue:6

    Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Humans; Immunosuppression Therap

1991
[Cytomegalovirus ileocolitis in patients with HIV infection is a treatable cause of severe abdominal problems].
    Lakartidningen, 1991, Dec-04, Volume: 88, Issue:49

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cecum; Crohn Disease; Cytomegalovirus I

1991
Foscarnet and penile ulceration.
    Lancet (London, England), 1990, Feb-03, Volume: 335, Issue:8684

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Herpes

1990
Penile ulcerations with foscarnet.
    Lancet (London, England), 1990, Mar-03, Volume: 335, Issue:8688

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet;

1990
[Treatment of Cytomegalovirus infection].
    La Revue du praticien, 1990, Feb-21, Volume: 40, Issue:6

    Topics: Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immune Tolerance; Phos

1990
Foscarnet therapy of cytomegalovirus retinitis in AIDS.
    Journal of acquired immune deficiency syndromes, 1990, Volume: 3, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Humans;

1990
Nephrogenic diabetes insipidus associated with foscarnet treatment of cytomegalovirus retinitis.
    Annals of internal medicine, 1990, Jun-15, Volume: 112, Issue:12

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Diabetes In

1990
Fixed drug eruption due to foscarnet.
    Genitourinary medicine, 1990, Volume: 66, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Drug Erupti

1990
Prevention of foscarnet nephrotoxicity.
    Annals of internal medicine, 1990, Aug-15, Volume: 113, Issue:4

    Topics: Adult; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Female; Fluid Therapy; F

1990
Wider access provided to AIDS drugs with actions against HIV, CMV infections.
    JAMA, 1990, Oct-17, Volume: 264, Issue:15

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; HIV Inf

1990
[Chemotherapy of cytomegalovirus infections].
    Nihon rinsho. Japanese journal of clinical medicine, 1989, Volume: 47, Issue:2

    Topics: Acyclovir; Adenine; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Organophosphonates;

1989
[Diagnosis and treatment of cytomegalovirus infections].
    Nihon rinsho. Japanese journal of clinical medicine, 1989, Volume: 47, Issue:2

    Topics: Acyclovir; Antigens, Viral; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Female; Foscarn

1989
Foscarnet in the treatment of cytomegalovirus retinitis in acquired immune deficiency syndrome.
    Ophthalmology, 1989, Volume: 96, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Adult; Creatine; Cytomegalovirus Infections; Drug Therapy, Combi

1989
Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
    Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Calcium; Cytomegalovirus Infections; Fo

1989
Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis.
    Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet;

1989
Foscarnet nephrotoxicity: mechanism, incidence and prevention.
    American journal of nephrology, 1989, Volume: 9, Issue:4

    Topics: Acute Kidney Injury; Adult; Aged; Cohort Studies; Creatinine; Cytomegalovirus Infections; Fluid Ther

1989
Foscarnet prophylaxis in marrow transplant recipients.
    Bone marrow transplantation, 1989, Volume: 4, Issue:6

    Topics: Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Humans; Nucleic

1989
Evaluation by immune scanning electron microscopy of foscarnet treatment of cytomegalovirus infection in patients with renal transplants.
    Scandinavian journal of infectious diseases, 1989, Volume: 21, Issue:6

    Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Cytomegalovirus; Cytomegalovirus Infections; Drug

1989
Tubulointerstitial nephritis caused by the antiviral agent foscarnet.
    Transplant international : official journal of the European Society for Organ Transplantation, 1989, Volume: 2, Issue:4

    Topics: Adult; Antiviral Agents; Cytomegalovirus Infections; Female; Foscarnet; Humans; Kidney Transplantati

1989
Foscarnet infusion at home.
    Lancet (London, England), 1989, Jan-21, Volume: 1, Issue:8630

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Drug Admini

1989
Treatment of CMV retinitis in an AIDS patient.
    The British journal of ophthalmology, 1987, Volume: 71, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarn

1987
Aerosol administration of antiviral agents to treat lung infection due to murine cytomegalovirus.
    The Journal of infectious diseases, 1988, Volume: 157, Issue:2

    Topics: Acyclovir; Administration, Oral; Aerosols; Animals; Antiviral Agents; Cytomegalovirus Infections; Di

1988
Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (Foscarnet).
    The Journal of infectious diseases, 1988, Volume: 157, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet;

1988
[Cytomegaloviruses and antiviral agents--a review].
    Lakartidningen, 1988, Mar-16, Volume: 85, Issue:11

    Topics: Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Humans; Phosphonoacetic Acid

1988
Acute renal failure induced by foscarnet: 4 cases.
    Clinical nephrology, 1988, Volume: 29, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adult; Antiviral Agents; Chorioretinitis; C

1988
Effect of Foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS.
    The Journal of infectious diseases, 1988, Volume: 158, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; HIV; HI

1988
Failure of antiviral therapy for acquired immunodeficiency syndrome-related cytomegalovirus myelitis.
    Archives of neurology, 1988, Volume: 45, Issue:10

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Cytomegalovirus Infections;

1988
Foscarnet as treatment for cytomegalovirus retinitis following bone marrow transplantation.
    Postgraduate medical journal, 1988, Volume: 64, Issue:751

    Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; Busulfan; Cataract; Cytomegalovirus Infections

1988
Foscarnet for cytomegalovirus pneumonitis.
    Lancet (London, England), 1985, May-18, Volume: 1, Issue:8438

    Topics: Adult; Cytomegalovirus Infections; Foscarnet; Humans; Male; Organophosphorus Compounds; Phosphonoace

1985
Foscarnet for cytomegalovirus infections.
    Lancet (London, England), 1985, Jun-29, Volume: 1, Issue:8444

    Topics: Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Humans; Organophosphorus Compounds; Phospho

1985
Foscarnet infusion at home.
    Lancet (London, England), 1988, Dec-03, Volume: 2, Issue:8623

    Topics: Acquired Immunodeficiency Syndrome; Adult; Cytomegalovirus Infections; Foscarnet; HIV Antigens; Home

1988
Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipients.
    Scandinavian journal of infectious diseases, 1985, Volume: 17, Issue:2

    Topics: Adult; Bone Marrow Transplantation; Child; Cytomegalovirus Infections; Female; Foscarnet; Humans; Im

1985
Foscarnet for cytomegalovirus retinitis.
    Annals of internal medicine, 1985, Volume: 103, Issue:6 ( Pt 1)

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Humans;

1985
Clinical experiences with phosphonoformate (foscarnet) treatment of viral diseases following renal transplantation.
    Scandinavian journal of urology and nephrology. Supplementum, 1985, Volume: 92

    Topics: Adult; Aged; Antiviral Agents; Cytomegalovirus Infections; Female; Foscarnet; Herpes Simplex; Herpes

1985
Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 17, Issue:3

    Topics: Adult; Aged; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus Infections; Electrolytes

1986
Deoxythymidine kinase, a possible marker for monitoring activity of cytomegalovirus infection after renal transplantation.
    Scandinavian journal of urology and nephrology, 1986, Volume: 20, Issue:1

    Topics: Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Humans; Kidney Transplantation; Male; Middl

1986
Serum thymidine kinase in transplant patients: its relation to cytomegalovirus activity, renal transplant rejection and its use for monitoring of antiviral therapy.
    Annals of clinical research, 1986, Volume: 18, Issue:2

    Topics: Adult; Antiviral Agents; Cell Division; Cytomegalovirus Infections; Female; Foscarnet; Graft Rejecti

1986
[Importance of Foscarnet in the treatment of cytomegalovirus pneumopathy in a patient with acquired immunodeficiency syndrome].
    Presse medicale (Paris, France : 1983), 1986, Nov-15, Volume: 15, Issue:40

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet;

1986
[Prevention and treatment of cytomegalovirus infections after graft of allogenic bone marrow].
    Nouvelle revue francaise d'hematologie, 1987, Volume: 29, Issue:1

    Topics: Acyclovir; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus Infections; Foscarnet; Gan

1987
Treatment of cytomegalovirus pneumonitis with foscarnet (trisodium phosphonoformate) in patients with AIDS.
    Journal of medical virology, 1987, Volume: 22, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet;

1987